SPDR Dow Jones Industrial Average ETF

SPDR S&P 500 ETF Trust

Invesco QQQ Trust Series 1

Advanced Micro Devices, Inc. engages in the semiconductor business. Its products include processors, accelerators, graphics, adaptive SoCs, FPGAs, and SOMs, and software, tools, and apps. The firm offers artificial intelligence, industries, workloads, and gaming solutions. The company was founded by W. J. Sanders III on May 1, 1969 and is headquartered in Santa Clara, CA.

Advanced Micro Devices Inc.

Advanced Micro Devices Inc

A broad semiconductor and AI-stock rebound, as concerns over slowing AI spending and higher yields eased, has lifted AMD sharply alongside peers. Traders are predominantly bullish and discussing momentum, call activity and a possible short squeeze, while some warn the move is overextended and vulnerable to profit-taking.

NEAR Protocol is the blockchain for AI. A high-performance, AI-native platform built to power the next generation of decentralized applications and intelligent agents. It provides the infrastructure AI needs to transact, operate, and interact across Web2 and Web3. NEAR combines three core elements: User-Owned AI, which ensures agents act in users’ best interests; Intents and Chain Abstraction, which eliminate blockchain complexity for seamless, goal-driven transactions across chains; and a sharded blockchain architecture that delivers the scalability, speed, and low-cost execution needed for real-world AI and Web3 use. This integrated stack makes NEAR the foundation for building secure, user-owned, AI-native applications at internet scale.

Near

NEAR is drawing attention after a sharp rally that traders link to the reported launch of confidential perpetuals on Hyperliquid, reinforcing the tokens AI, privacy and cross-chain infrastructure narrative. Bullish traders point to short liquidations and breakout momentum, while others view the move as a possible pump and expect a pullback.

Ultragenyx Pharmaceutical, Inc. is a biopharmaceutical company, which engages in the identification, acquisition, development, and commercialization of novel products for the treatment of genetic diseases. Its products include Crysvita, Mepsevii, Dojolvi, and Evkeeza. The company was founded by Emil D. Kakkis in April 2010 and is headquartered in Novato, CA.

Ultragenyx Pharmaceutical Inc.

Ultragenyx Pharmaceutical Inc

FDA granted full approval to Fayuvi, Ultragenyxs gene therapy for Sanfilippo syndrome type A, making it the first approved treatment for the disorder and adding a Priority Review Voucher. Traders are broadly bullish on the commercial and valuation impact, though some debate the muted share-price response, limited patient population, cash burn, and potential profit-taking.

Iovance Biotherapeutics, Inc. engages in the development and commercialization of cell therapies using autologous tumor-infiltrating lymphocytes (TIL) for the treatment of cancer. Its products include Amtagvi (lifileucel), and Proleukin (aldesleukin). The firm also develops investigational TIL therapies for other solid tumor cancers. The company was founded by Robert T. Brooke on September 17, 2007 and is headquartered in San Carlos, CA.

Iovance Biotherapeutics Inc

Barclays bullish reassessment of Lifileucel, supported by a physician survey and anticipation of the IOV-LUN-202 lung-cancer update, has intensified attention around Iovance alongside expectations for updated commercial guidance. Traders are broadly bullish on Amtagvis momentum and future indications, while others attribute the volatile move to profit-taking, options positioning, and possible short covering.

Micron Technology, Inc. engages in the provision of innovative memory and storage solutions. It operates through the following segments: Cloud Memory Business Unit (CMBU), Core Data Center Business Unit (CDBU), Mobile and Client Business Unit (MCBU), and Automotive and Embedded Business Unit (AEBU). The CMBU segment focuses on memory solutions for large hyperscale cloud customers and High-Bandwidth Memory for all data center customers. The CDBU segment is involved in memory solutions for mid-tier cloud, enterprise, and OEM data center customers and storage solutions for all data center customers. The MCBU segment focuses on memory and storage solutions for the mobile and client segments. The AEBU segment is involved in memory and storage solutions for the automotive, industrial, and consumer segments. The company was founded by Ward D. Parkinson, Joseph Leon Parkinson, Dennis Wilson, and Doug Pitman on October 5, 1978 and is headquartered in Boise, ID.

Micron Technology Inc.

Micron Technology Inc

Anticipation of Microns upcoming earnings is driving attention, with traders focusing on AI-related demand, tight DRAM/HBM supply, rising memory prices and expectations for strong results. Bullish participants see sustained pricing power and data-center growth, while skeptics cite cyclicality, elevated valuations, rates and potential AI-spending weakness as risks.

Invesco QQQ Trust Series 1 - Invesco QQQ Trust Series 1

A tech-led rebound in the Nasdaq, supported by falling Treasury yields and oil prices despite the Federal Reserves rate hike, is driving attention to QQQ. Traders are split between viewing the move as a bullish short squeeze and relief rally, versus warning that low volume, elevated valuations, geopolitical risks, and the Bank of Japans rate decision could trigger a pullback.

Reddit, Inc. operates an entertainment, social networking, and news website where registered community members can submit content. The firm provides online news services where users can select and rank web content. It also offers a personalized filter on the day's story, using previous votes to determine what new things the user might like to read. The company was founded by Steven Ladd Huffman and Alexis Ohanian on June 23, 2005 and is headquartered in San Francisco, CA.

Reddit Inc. - Ordinary Shares - Class A

Reddit Inc

Uncertainty around Reddits renewal of its Google AI/data-licensing agreement is the dominant catalyst, with traders looking for concrete terms or a deal update. The CEOs comments that negotiations remain active, without a clear agreement, have fueled skepticism, while some bulls point to accelerating user growth and advertising momentum as offsets.

Shiba Inu (SHIB) is a decentralized, community-led cryptocurrency ecosystem built on the Ethereum blockchain. Originally launched as a meme-based project, it has evolved into a comprehensive financial ecosystem designed to offer a decentralized alternative to traditional banking. Its main value proposition lies in its transition from a social phenomenon into a functional utility network, supported by a vast global community known as the ShibArmy and a commitment to 100% community ownership with no central leadership.  The ecosystem features its own decentralized exchange, ShibaSwap, where users can trade, provide liquidity, and earn rewards. To address Ethereum’s high costs and slow speeds, the project utilizes Shibarium, a Layer 2 scaling solution that processes transactions faster and more affordably.  The project employs a unique three-token model to manage its economy and governance. SHIB serves as the primary currency for trading and payments, while LEASH offers scarcity-based incentives for dedicated supporters. BONE acts as the governance token, allowing holders to vote on proposals through the Doggy DAO and serving as the native gas token for the Shibarium network.

Shiba Inu

A sharp SHIB rebound and renewed meme-coin momentum are driving attention, with traders highlighting rising volume, higher highs and increased trending visibility. The community is largely bullish and adding or holding positions, although some traders view the move as a recurring pump-and-dump pattern and remain skeptical of SHIBs long-term prospects.

Fluence Energy, Inc. engages in energy storage products and services, and artificial intelligence-enabled digital applications for renewables and storage. Its storage includes Smartstack, Gridstack Pro, Grisdtack, and Ultrastack. The company was founded on June 21, 2021, and is headquartered in Arlington, VA.

Fluence Energy Inc - Ordinary Shares - Class A

A second FY2026 guidance cut, attributed to ongoing ramp-up delays at Fluences Houston contract-manufacturing facility, has driven heavy selling and a wave of analyst downgrades focused on execution and margin risk. Traders remain divided between those questioning managements credibility and warning of further downside, and dip buyers arguing that strong storage demand and backlog could support a recovery if production improves.

Intel Corp. engages in the design, manufacture, and sale of computer products and technologies. It delivers computer, networking, data storage, and communications platforms. The firm operates through the following segments: Client Computing Group (CCG), Data Center and AI (DCAI), Intel Foundry Services (IFS), and All Other. The CCG segment consists of platforms designed for notebooks, 2-in-1 systems, desktops, tablets, phones, wireless and wired connectivity products, and mobile communication components. The DCAI segment delivers solutions to cloud service providers and enterprise customers, along with silicon devices for communications service providers and high-performance computing customers. The IFS segment refers to full stack solutions created from the foundry industry ecosystem. The All Other segment represents results from other non-reportable segments and corporate-related charges. The company was founded by Robert Norton Noyce and Gordon Earle Moore on July 18, 1968, and is headquartered in Santa Clara, CA.

Intel Corp.

Intel Corp

Reported exploratory talks for SK Hynix to use Intels Ohio facilities or form a joint venture for U.S. memory-chip production are driving attention, with traders viewing the potential partnership as a boost to Intels foundry strategy amid strong AI-related memory demand. The community is broadly bullish and discussing short-covering and options-driven momentum, although skeptics note that SK Hynix says no specific plan or agreement has been finalized.

statis crypto Watchlist

Bitcoin

Ethereum

Solana

Ripple

Dogecoin

Cardano

statis IN Watchlist

Nifty 50

Nifty Bank

Reliance Industries Ltd.

Zomato Ltd.

Tata Consultancy Services

Tata Motors Ltd.

HDFC Bank Ltd.

ITC Ltd.

Adani Enterprises Ltd

Axis Bank Ltd

Bajaj Finance Ltd

statis US Watchlist

SPDR S&P 500 ETF

Apple Inc.

Tesla Inc

Microsoft Corporation

NVIDIA Corp

 Hey, I want to invite you to join Stocktwits. It’s the largest global community of active traders. You’ll get access to the real-time market insights, news, discussion and much more! You can sign up using my unique link below 
 


 has invited you to join Stocktwits

Blossomhill Therapeutics, Inc. is a clinical-stage biopharmaceutical company. It engages in the development of small molecule medicines for unmet medical needs in cancer treatment. The company was founded on June 22, 2020 and is headquartered in San Diego, CA.

BlossomHill Therapeutics Inc..

Bearish Sentiment

No more this year

One more

Two more

The Federal Reserve raised interest rates by a quarter point to a range of 3.75%-4.00% on Wednesday, its first hike since July 2023, but Fed Chair Kevin Warsh signaled the tightening cycle isn't over. How many more rate hikes do you expect by the end of 2026? Vote and explain your reasoning in the comments.

The Fed hiked rates 25bps yesterday, its first since 2023, but signaled it&#39;s not done - projections point to one or two more hikes this year. How many total hikes do you expect by year-end?

Stocktwits

The Fed hiked rates 25bps yesterday, its first since 2023, but signaled it's not done - projections point to one or two more hikes this year. How many total hikes do you expect by year-end?

Current Price	$26.82
Prev Close	$26.25
Open	$26.49
Dividend Yield	N/A
50-Day Moving Average	$18.98
Beta	0.00
Avg. Volume	303,695.96
PE Ratio	N/A

52-Week High	$27.80
52-Week Low	$15.25
Market Capitalization	$804.4M
EPS (Annual)	-$1.98
Price to Book	-5.40
Revenue Per Employee	$0.00

Feed

News

Sentiment

Fundamentals

Info

BLSM Fundamentals